300871.SZ SHZ
Hvsen Biotechnology Co., Ltd.
1W: -2.8%
1M: -6.4%
3M: -9.7%
YTD: -22.1%
1Y: -7.9%
3Y: +27.2%
5Y: -48.0%
¥21.10 ($3.15)
+0.48 (+2.33%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$3.0B
+1.3% ▲
5Y CAGR: +35.9%
Total Liabilities
$1.5B
+5.7% ▲
5Y CAGR: +41.6%
Shareholders Equity
$1.5B
-3.4% ▼
5Y CAGR: +31.0%
Cash & Investments
$527M
-11.8% ▼
5Y CAGR: +38.2%
Total Debt
$872M
+3.6% ▲
5Y CAGR: +63.1%
Net Debt
$546M
-0.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $345M | $1.1B | $424M | $294M | $326M |
| Short-Term Investments | $241M | $30M | $362M | $304M | $201M |
| Cash & ST Investments | $586M | $1.1B | $786M | $598M | $527M |
| Net Receivables | $236M | $251M | $356M | $372M | $454M |
| Inventory | $127M | $232M | $199M | $229M | $248M |
| Other Current Assets | $204M | $19M | $12M | $5M | $12M |
| Total Current Assets | $1.2B | $1.6B | $1.4B | $1.3B | $1.3B |
| Property, Plant & Equip. | $412M | $1.0B | $1.5B | $1.6B | $1.5B |
| Goodwill & Intangibles | $96M | $110M | $107M | $104M | $114M |
| Long-Term Investments | $2M | $0 | $12M | $0 | $0 |
| Other Non-Current Assets | $57M | $15M | $8M | $17M | $17M |
| Total Non-Current Assets | $575M | $1.1B | $1.6B | $1.7B | $1.7B |
| Total Assets | $1.8B | $2.7B | $3.0B | $3.0B | $3.0B |
| — Liabilities — | |||||
| Accounts Payable | $194M | $249M | $490M | $472M | $507M |
| Short-Term Debt | $63M | $106M | $220M | $241M | $317M |
| Deferred Revenue | $55M | $76M | $85M | $0 | $0 |
| Other Current Liabilities | $26M | $40M | $80M | $68M | $54M |
| Total Current Liabilities | $339M | $503M | $805M | $781M | $923M |
| Long-Term Debt | $0 | $575M | $570M | $602M | $555M |
| Other Non-Current Liab. | $10M | $45M | $2M | $845K | $1M |
| Total Non-Current Liabilities | $34M | $620M | $643M | $685M | $626M |
| Total Liabilities | $373M | $1.1B | $1.4B | $1.5B | $1.5B |
| — Equity — | |||||
| Common Stock | $111M | $166M | $166M | $166M | $166M |
| Retained Earnings | $312M | $382M | $376M | $342M | $277M |
| Accumulated OCI | $957M | $190M | $122M | $0 | $0 |
| Total Stockholders Equity | $1.4B | $1.6B | $1.5B | $1.5B | $1.5B |
| Total Liabilities & Equity | $1.8B | $2.7B | $3.0B | $3.0B | $3.0B |
| — Key Metrics — | |||||
| Total Debt | $73M | $681M | $790M | $842M | $872M |
| Net Debt | -$273M | -$387M | $366M | $549M | $546M |
| Total Investments | $243M | $30M | $374M | $304M | $201M |